Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. - sprookjes - yvandenbroek - TriplyDB

Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.

Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.

http://www.wikidata.org/entity/Q39179249

about

Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1 Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities Calcium signaling and secretion in cholangiocytes Targeting Angiogenesis in Biliary Tract Cancers: An Open Option Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.De-SUMOylation of FOXC2 by SENP3 promotes the epithelial-mesenchymal transition in gastric cancer cells.Pathogenesis, diagnosis, and management of cholangiocarcinoma 15-Deoxy-Δ(12,14)-Prostaglandin J2 Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox Pathway The dynamics of Rho GTPase signaling and implications for targeting cancer and the tumor microenvironment.Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat Integrin β6 serves as an immunohistochemical marker for lymph node metastasis and promotes cell invasiveness in cholangiocarcinoma.Contribution of Myofibroblasts of Different Origins to Liver Fibrosis Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.Molecular mechanism of cholangiocarcinoma carcinogenesis.Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape.Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.Emerging concepts in biliary repair and fibrosis.Posttranslational regulation of polycystin-2 protein expression as a novel mechanism of cholangiocyte reaction and repair from biliary damage.Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4.Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview.Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis.The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.Platelet-derived growth factor D: a new player in the complex cross-talk between cholangiocarcinoma cells and cancer-associated fibroblasts.Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma.A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer

P2860

Q24309719-4474DE2E-91A8-4C96-B560-261278702192 Q26765903-80B735E6-9F20-47BF-ABE3-C621D8ED2650 Q26771988-973F6F7D-DCB5-4CB4-BECF-06D48E703BDD Q26778344-2E2322E4-CFDD-4491-9A86-E48C89EE3D1A Q28391016-91DC7A3D-CC40-4DED-AEC1-2848807D5DC9 Q30398807-1C6093F7-D7CD-4A6D-BBB8-2B957CC920E0 Q34044638-43EB1971-8284-4CC6-AECE-C4400545C23B Q34334509-2D08A83C-ADBF-41F1-9FB5-8CE4DBC55ED1 Q34656747-787F1EE8-628A-47B5-8167-98756D7FF58E Q36119037-4195D180-B1FC-434F-9AF2-CA83EC01B499 Q36147572-20507C75-7573-4EAF-A6DF-81ADCD97E61F Q37082378-3305EE6A-33D2-4818-9D7B-35D659B550FD Q37112868-3D4ABB00-7328-497C-8401-72F64BD5CE02 Q37128332-8856B09E-AF5C-46B1-9ECB-03E83620A04C Q38152382-E44021B8-1E84-4F6F-A65B-FBB299D882EE Q38217475-6B74D6DD-23BB-4877-83A0-DB44BF6C37C9 Q38245527-010EF753-F003-451A-A6C2-A9CC14C3DF45 Q38543837-16E2E446-F0D9-4F51-BAED-173690548E5E Q38601575-0A60CC91-8D07-41DA-93AC-55BD50576878 Q38720813-A360D9BF-5A1E-4BA7-ADD0-47D9290E0395 Q38762992-BED5AAE6-F37E-4403-983C-2545EF4458F8 Q38812588-4E0A79CB-9D90-4879-AE9D-CDC1007F82D3 Q38841880-F6FB67A9-A74A-468F-81EF-2EBA46623212 Q39137066-6280C61F-D9E7-4FDE-A987-692130C6252A Q39319145-75F1C356-283B-4FC6-8323-A67877912796 Q41815845-D0592490-822C-4C3F-87DA-BC1814A7D1CD Q42272472-E7AAFE7F-C86E-4AE1-AD2A-DF8CAE206A82 Q42371988-C1FF344C-4AB4-41E6-A6D3-E9F071DBDA37 Q47161447-40ABB386-00FF-4174-A7BF-987096E1C53B Q47603972-FD6C1780-DD90-4114-ABA8-F4A148F61BBD Q47756210-5AB8C203-A970-4A64-A796-118428068D8D Q50350640-5C0E6CA3-1782-427F-B98D-FD3AF2C21077 Q50972322-BF9F6AE6-0E29-42FF-B4F3-5F3D76474B11 Q52729640-3FB79CC1-43E2-40D2-8C67-B0305AFF3C82 Q59125685-525D292D-E043-471A-AE5C-B6DF6B9E3FE8 Q59138139-C4904D1A-DE7B-41BF-A298-7C29FAC21AB2

P2860

Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.

http://www.wikidata.org/entity/Q39179249

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Platelet-derived growth factor ...... oblasts in cholangiocarcinoma.

@en

Platelet-derived growth factor ...... oblasts in cholangiocarcinoma.

@nl

type

label

Platelet-derived growth factor ...... oblasts in cholangiocarcinoma.

@en

Platelet-derived growth factor ...... oblasts in cholangiocarcinoma.

@nl

prefLabel

Platelet-derived growth factor ...... oblasts in cholangiocarcinoma.

@en

Platelet-derived growth factor ...... oblasts in cholangiocarcinoma.

@nl

P1433

Q39179249-55AD7AE4-C037-4361-BC51-06266318656E

P1476

Q39179249-5FF170B7-0BD1-4AFA-B9E6-632627514EC2

P2093

Q39179249-0010ADA5-A023-4E9A-ABDA-CE74C643E0F8

Q39179249-06A416C0-25B7-4D1C-AED2-1577144BF8EC

Q39179249-2EF9DAB8-2A97-4D85-9755-ADBD2E3807F4

Q39179249-50F10208-1C7C-4A45-B999-2092DD2EAB3D

Q39179249-69837BCA-AC4B-44B7-BE12-3822D98FF54F

Q39179249-844DB9F8-8903-4726-9930-760F4480CB53

Q39179249-B68E5E07-161A-4CED-8645-870116B81C56

Q39179249-C8174CE3-0A64-4617-AFF7-34F6ACD5FFE3

Q39179249-DC3C74F1-3810-40CA-8C5D-0F59DF411617

Q39179249-FC4F4922-C8DE-4BEB-9B89-F0D5D7753C26

P2860

Q39179249-04871723-E275-493E-BDDA-DA7AB29BBFAD

Q39179249-1B1FBD78-80D2-4C14-BEDD-8EB1B66F8344

Q39179249-1DA09936-219D-4D9D-AE8D-882299B40C99

Q39179249-2D2874EF-0C86-40F8-9A8E-F23DF7EB18F8

Q39179249-31BC014B-9517-401D-AF64-58CDCBBF26D5

Q39179249-3FC6135B-31FC-498A-B8FB-D29A10281104

Q39179249-44A5539A-30A5-4BA1-AB43-9449C0B5BE06

Q39179249-45AE5C35-A689-45DC-B2E6-4A06813CFE83

Q39179249-4DBD7999-E02A-495F-8ABF-3FEF999FE3FB

Q39179249-5AC763D8-B770-4D18-935E-B11E8DDEC863

P304

Q39179249-123025DA-723E-45DF-BF88-D804E8A88961

P31

Q39179249-59316A31-ADEB-4A59-9580-ADDAE0817721

P356

Q39179249-825EC280-4EB5-4F50-9186-4D01120ECBC1

P407

Q39179249-305FF457-4504-4EC2-AA93-0ADB0B56A1A8

P433

Q39179249-1F183A14-BD44-4655-B74F-A2AC82263BE0

P478

Q39179249-04D6EE2D-FFAE-4EC2-9D70-0CA5EB0A2E83

P50

Q39179249-118EEED0-BE63-4F5A-BBE7-41E3F38D1826

Q39179249-2F1149EA-6BFA-4447-8F51-AB99E36AD459

Q39179249-4BAB6114-B808-45D3-AED4-0E94E34F1525

Q39179249-5AF6D5B1-8918-4431-9E3F-E2CF4F44053B

Q39179249-97315D50-52BE-4743-A66C-F37E98B4CF6E

Q39179249-C665DE17-6290-4325-BDD5-8371FDEAED6B

P577

Q39179249-D9678611-AE56-4CF8-861F-CFA274048AAF

P698

Q39179249-3880F2D8-910C-42AF-859E-8A329DC4B552

P921

Q39179249-5E2CCE41-975C-4165-8578-EF4B605C9D46

P932

Q39179249-24DABE85-DD68-41C8-B87E-17FACC05E4AB

P356

P1433

P1476

Platelet-derived growth factor ...... oblasts in cholangiocarcinoma.

@en

P2093

Carlo Spirli

http://www.w3.org/2001/XMLSchema#string

Giorgia Nardo

http://www.w3.org/2001/XMLSchema#string

Irene Franceschet

http://www.w3.org/2001/XMLSchema#string

Luca Fabris

http://www.w3.org/2001/XMLSchema#string

Luigi Dall'olmo

http://www.w3.org/2001/XMLSchema#string

Luisa Sambado

http://www.w3.org/2001/XMLSchema#string

Marco Massani

http://www.w3.org/2001/XMLSchema#string

Mario Strazzabosco

http://www.w3.org/2001/XMLSchema#string

Nicolò Bassi

http://www.w3.org/2001/XMLSchema#string

Romina Fiorotto

http://www.w3.org/2001/XMLSchema#string

P2860

Epithelial-mesenchymal transitions in development and disease

Rho GTPases in cell biology

Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells (HSC)

Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases

Pro-fibrogenic potential of PDGF-D in liver fibrosis

Fibroblasts in cancer

Friends or foes - bipolar effects of the tumour stroma in cancer

Emerging roles of PDGF-D signaling pathway in tumor development and progression.

Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor

PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.

P304

1042-1053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.26384

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Massimiliano Cadamuro

Stefano Indraccolo

Michele Colledan

P577

2013-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23505219

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

3732815

http://www.w3.org/2001/XMLSchema#string